JANINE N DISANTI

Eye and Vision Services Providers|Optometrist PENNINGTON, NJ NPI 1215486147

General Payments — all program years on this page

$2,098.56

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $768.32 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $768.3219

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Bausch & Lomb Americas Inc. $300.989
RxSight Inc $232.102
Dompe US, Inc. $132.544
SUN PHARMACEUTICAL INDUSTRIES INC. $46.302
Coherus Biosciences Inc. $40.371
ABBVIE INC. $16.031

By program year

Program yearAmountRecords
2018 $218.7512
2019 $264.0418
2020 $27.822
2022 $65.994
2023 $753.6420
2024 $768.3219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103645024 ABBVIE INC. $16.03 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360372 Bausch & Lomb Americas Inc. $14.68 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360374 Bausch & Lomb Americas Inc. $0.83 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360376 Bausch & Lomb Americas Inc. $1.25 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360378 Bausch & Lomb Americas Inc. $123.57 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360380 Bausch & Lomb Americas Inc. $17.81 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360382 Bausch & Lomb Americas Inc. $14.00 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360384 Bausch & Lomb Americas Inc. $14.00 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360386 Bausch & Lomb Americas Inc. $7.62 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140360388 Bausch & Lomb Americas Inc. $107.22 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144215609 RxSight Inc $128.40 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144215611 RxSight Inc $103.70 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147273770 Coherus Biosciences Inc. $40.37 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151405133 Dompe US, Inc. $34.64 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151405135 Dompe US, Inc. $33.46 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151405137 Dompe US, Inc. $34.44 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151405139 Dompe US, Inc. $30.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152157037 SUN PHARMACEUTICAL INDUSTRIES INC. $18.04 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152157039 SUN PHARMACEUTICAL INDUSTRIES INC. $28.26 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.